On May 12, 2023, Paratek Pharmaceuticals, Inc announced that it has filed a preliminary proxy statement soliciting proxies and urged the shareholders to vote for its board nominees: Minnie Baylor-Henry, Michael F. Bigham and Robert S. Radie at the Companyâs annual general meeting scheduled to be held on July 6, 2023.
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |